January 2022 FDA Recall Drug by Ingenus Pharmaceuticals Llc
D-0374-2022 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Ingenus Pharmaceuticals Llc on January 10, 2022 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0374-2022

Reason for Recall
CGMP Deviations
Initiated
01-10-2022
Reported
01-26-2022
Quantity
45,173 cans

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Ingenus Pharmaceuticals Llc
Nationwide in the USA
Clobetasol Propionate Foam, 0.05%, packaged in a) 50 g can (NDC 50742-304-50), and b) 100 g can (NDC 50742-304-01), Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC, Orlando, FL 32839-6408.

Batch or Lot Expiration Information

Lot# a) Lots: 32921 Exp. 06/2022; 33152 Exp. 08/2022; 33340 Exp. 11/2022; b) Lots: 33152 Exp. 08/2022; 33340 Exp. 11/2022.